Cargando…

Do biological disease-modifying antirheumatic drugs reduce the spinal fracture risk related to ankylosing spondylitis? A longitudinal multiregistry matched cohort study

OBJECTIVES: Ankylosing spondylitis (AS) is associated with an increased spinal fracture risk due to the loss of elasticity in spinal motion segments. With the introduction of biological disease-modifying antirheumatic drug (bDMARD) treatment for AS, the individual course of the disease has been amel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, Yohan, Olerud, Claes, Willander, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Rheumatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770921/ https://www.ncbi.nlm.nih.gov/pubmed/29288176 http://dx.doi.org/10.1136/bmjopen-2017-016548

Ejemplares similares

Surgical Stabilization Improves Survival of Spinal Fractures Related to Ankylosing Spondylitis
por: Robinson, Yohan, et al.
Publicado: (2015)

Survival after surgery for spinal metastatic disease: a nationwide multiregistry cohort study
por: Carrwik, Christian, et al.
Publicado: (2021)

Delayed Diagnosis of Ankylosing Spondylitis: A Missed Opportunity?
por: Patel, Pooja, et al.
Publicado: (2019)

Evaluation of Access Disparities to Biologic Disease-Modifying Antirheumatic Drugs in Rural and Urban Communities
por: Peterman, Nicholas J, et al.
Publicado: (2022)

Increased occurrence of spinal fractures related to ankylosing spondylitis: a prospective 22-year cohort study in 17,764 patients from a national registry in Sweden
por: Robinson, Yohan, et al.
Publicado: (2013)

The Role of the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Markers of Disease Activity in Ankylosing Spondylitis
por: Zeb, Alam, et al.
Publicado: (2019)

Effects of traditional qigong exercise on ankylosing spondylitis: a protocol for systematic reviews and meta-analysis
por: Liu, Wei, et al.
Publicado: (2021)

Increasing proportion of female patients with ankylosing spondylitis: a population-based study of trends in the incidence and prevalence of AS
por: Haroon, Nisha N, et al.
Publicado: (2014)

Factors associated with disease-specific quality of life in Taiwanese patients with ankylosing spondylitis: a cross-sectional study
por: Lu, Ming-Chi, et al.
Publicado: (2019)

Tuberculosis among patients treated with TNF inhibitors for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in Slovenia: a cohort study
por: Rotar, Ziga, et al.
Publicado: (2020)

Finite Element Analysis of Long Posterior Transpedicular Instrumentation for Cervicothoracic Fractures Related to Ankylosing Spondylitis
por: Robinson, Yohan, et al.
Publicado: (2018)

Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis
por: Rahman, Proton, et al.
Publicado: (2016)

Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland
por: Burkard, Theresa, et al.
Publicado: (2022)

The importance of the occipitocervical area in patients with ankylosing spondylitis analysis of a cohort of 86 cervical fractures in surgically treated patients
por: Covaro, Augusto Atilio, et al.
Publicado: (2017)

Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in Germany
por: Krüger, Klaus, et al.
Publicado: (2018)

A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers
por: Ng, Bernard, et al.
Publicado: (2013)

Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study
por: Hendricks, Oliver, et al.
Publicado: (2019)

A long-term, observational cohort study on the safety of low-dose glucocorticoids in ankylosing spondylitis: adverse events and effects on bone mineral density, blood lipid and glucose levels and body mass index
por: Zhang, Yu-Ping, et al.
Publicado: (2015)

Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis
por: Paul, Sanjoy K, et al.
Publicado: (2021)

Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)
por: Uhrenholt, Line, et al.
Publicado: (2019)

The Relationship between the Occipitocervical Junction and Thoracic Kyphosis in Ankylosing Spondylitis: A Retrospective Cohort Study of 86 Cervical Fractures in Surgically Treated Patients
por: Manabe, Nodoka, et al.
Publicado: (2019)

Conventional disease-modifying antirheumatic drugs therapy may not slow spinal radiographic progression in ankylosing spondylitis: results from an 18-year longitudinal dataset
por: Lee, Tae-Han, et al.
Publicado: (2020)

Effect of a 12-week high-intensity exercise intervention: a comparison of cardiac exercise adaptations during biological disease-modifying antirheumatic drug treatment (TNF inhibitors vs IL-6 signalling inhibitors) in patients with rheumatoid arthritis – study protocol for a randomised controlled trial
por: Jønck, Simon, et al.
Publicado: (2023)

Does knowledge of the primary tumour affect survival after surgery for spinal metastatic disease? A retrospective longitudinal cohort study
por: Carrwik, Christian, et al.
Publicado: (2021)

Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitis
por: Kim, Se Hee, et al.
Publicado: (2021)

Study protocol: Comparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of Structural damage in the spine over two years in patients with ankyLosing spondylitis (CONSUL) – an open-label randomized controlled multicenter trial
por: Proft, Fabian, et al.
Publicado: (2017)

Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis
por: Huang, Bin, et al.
Publicado: (2020)

Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences?
por: Baraliakos, X, et al.
Publicado: (2015)

Spinal instability in ankylosing spondylitis
por: Badve, Siddharth A, et al.
Publicado: (2010)

Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis
por: van der Heijde, Désirée, et al.
Publicado: (2019)

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
por: Ramiro, Sofia, et al.
Publicado: (2013)

Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study
por: Hafström, Ingiäld, et al.
Publicado: (2014)

Osteoarthritis: Can We Do Better?
por: Collins, Dylon P, et al.
Publicado: (2022)

Spinal deformity correction in ankylosing spondylitis
por: Maggio, Dominic, et al.
Publicado: (2022)

Do solar cycles influence giant cell arteritis and rheumatoid arthritis incidence?
por: Wing, Simon, et al.
Publicado: (2015)

Modifiable and non-modifiable risk factors in hip fracture mortality in Norway, 2014 to 2018: a linked multiregistry study
por: Kjærvik, Cato, et al.
Publicado: (2022)

An Ethnic Variation in the Acceptance of Biological Disease-Modifying Therapies: A University Hospital Experience
por: Selvaskandan, Haresh, et al.
Publicado: (2021)

Relationship between hormone replacement therapy and spinal osteoarthritis: a nationwide health survey analysis of the elderly Korean population
por: Park, Jung-Ho, et al.
Publicado: (2017)

Management of Acute Spinal Fractures in Ankylosing Spondylitis
por: Chaudhary, Saad B., et al.
Publicado: (2011)

Cohort profile: the Halland osteoarthritis (HALLOA) cohort–from knee pain to osteoarthritis: a longitudinal observational study in Sweden
por: Andersson, Maria L E, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uo56114d4gkj80l7osv6mf8vtq